Filings

1 document · 1 match

1. LRMR Larimar Therapeutics, Inc. 10-K 2026-03-19

   Item 1A. Risk Factors

   material weaknesses in internal control over financial reporting, our business and reputation may be harmed and our stock price may decline
   1 match in this document Show context Copy citation